On the public citation graph

Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients

https://doi.org/10.1128/jcm.00438-18
0 signed · 86 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10067-011-1771-9openalex-snapshot
Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea
inferredcites →https://doi.org/10.1016/j.cmi.2016.05.006openalex-snapshot
Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT
inferredcites →https://doi.org/10.1016/j.diagmicrobio.2012.11.023openalex-snapshot
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection
inferredcites →https://doi.org/10.1016/j.ijid.2009.08.001openalex-snapshot
Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature
inferredcites →https://doi.org/10.1016/j.jinf.2016.09.008openalex-snapshot
First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus
inferredcites →https://doi.org/10.1016/s0140-6736(15)00151-8openalex-snapshot
Tuberculosis
inferredcites →https://doi.org/10.1016/s1473-3099(11)70210-9openalex-snapshot
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/nrdp.2016.76openalex-snapshot
Tuberculosis
inferredcites →https://doi.org/10.1038/srep30617openalex-snapshot
Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan
inferredcites →https://doi.org/10.1086/514993openalex-snapshot
Mycobacterium tuberculosis Infection in Solid‐Organ Transplant Recipients: Impact and Implications for Management
inferredcites →https://doi.org/10.1093/cid/ciu185openalex-snapshot
Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis
inferredcites →https://doi.org/10.1097/00007890-199705150-00015openalex-snapshot
CLINICAL PRESENTATION AND OUTCOME OF TUBERCULOSIS IN KIDNEY, LIVER, AND HEART TRANSPLANT RECIPIENTS IN SPAIN1
inferredcites →https://doi.org/10.1111/j.1365-2249.2007.03462.xopenalex-snapshot
Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study
inferredcites →https://doi.org/10.1111/j.1582-4934.2007.00101.xopenalex-snapshot
Cell biology and clinical promise of G‐CSF: immunomodulation and neuroprotection
inferredcites →https://doi.org/10.1128/cvi.00199-15openalex-snapshot
Gamma Interferon Assays Used in the Diagnosis of Tuberculosis
inferredcites →https://doi.org/10.1128/jcm.02498-16openalex-snapshot
Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting
inferredcites →https://doi.org/10.1128/jcm.02803-15openalex-snapshot
Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
inferredcites →https://doi.org/10.1136/annrheumdis-2013-203348openalex-snapshot
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012
inferredcites →https://doi.org/10.1136/ard.2006.061937openalex-snapshot
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
inferredcites →https://doi.org/10.1136/ard.2010.146852openalex-snapshot
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
inferredcites →https://doi.org/10.1136/thoraxjnl-2015-207811openalex-snapshot
Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1164/rccm.200306-837ocopenalex-snapshot
Mycobacterium tuberculosis –specific CD8+ T Cells Preferentially Recognize Heavily Infected Cells
inferredcites →https://doi.org/10.1164/rccm.201405-0967ocopenalex-snapshot
Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study
inferredcites →https://doi.org/10.1183/09031936.00000712openalex-snapshot
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
inferredcites →https://doi.org/10.1183/09031936.00028510openalex-snapshot
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
inferredcites →https://doi.org/10.1183/09031936.00040007openalex-snapshot
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
inferredcites →https://doi.org/10.1183/09031936.00114810openalex-snapshot
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1183/13993003.00510-2016openalex-snapshot
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening
inferredcites →https://doi.org/10.1183/13993003.01245-2015openalex-snapshot
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
inferredcites →https://doi.org/10.1186/1471-2334-9-207openalex-snapshot
Performance of the tuberculin skin test and interferon-γ release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population
inferredcites →https://doi.org/10.1186/s12995-016-0148-zopenalex-snapshot
QFT-Plus: a plus in variability? – Evaluation of new generation IGRA in serial testing of students with a migration background in Germany
inferredcites →https://doi.org/10.1371/journal.pone.0032482openalex-snapshot
Interferon-γ Release Assays for the Diagnosis of Tuberculosis and Tuberculosis Infection in HIV-Infected Adults: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1371/journal.pone.0119260openalex-snapshot
QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment
inferredcites →https://doi.org/10.1371/journal.pone.0141033openalex-snapshot
The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy
inferredcites →https://doi.org/10.1371/journal.pone.0156917openalex-snapshot
Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age
inferredcites →https://doi.org/10.1378/chest.08-2575openalex-snapshot
Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
inferredcites →https://doi.org/10.2307/2529310openalex-snapshot
The Measurement of Observer Agreement for Categorical Data
inferredcites →https://doi.org/10.3899/jrheum.140099openalex-snapshot
Performance of the Tuberculin Skin Test and Interferon- Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches
inferredcites →https://doi.org/10.4049/jimmunol.1101122openalex-snapshot
Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.73.e167649zenodo-depositor-declared
Comparative results of two IGRA tests for determining the specific response against Mycobacterium tuberculosis infection
inferred← citeshttps://doi.org/10.1002/9781683674023.ch28openalex-snapshot
Interferon Gamma Release Assays for Tuberculosis Diagnosis
inferred← citeshttps://doi.org/10.1016/j.advms.2019.09.001openalex-snapshot
Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.arbr.2021.06.002openalex-snapshot
WITHDRAWN: Diagnosis of tuberculous infection in immunosuppressed patients and/or candidates for biologics using a combination of 2 IGRA tests: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus
inferred← citeshttps://doi.org/10.1016/j.arbres.2020.04.011openalex-snapshot
Diagnóstico de la infección tuberculosa en pacientes inmunodeprimidos y/o candidatos a terapias biológicas mediante el uso combinado de dos pruebas IGRA: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus
inferred← citeshttps://doi.org/10.1016/j.arbres.2020.04.026openalex-snapshot
[Translated article] Diagnosis of tuberculous infection in immunosuppressed patients and/or candidates for biologics using a combination of 2 IGRA tests: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus
inferred← citeshttps://doi.org/10.1016/j.cca.2022.05.028openalex-snapshot
Indeterminate results of QuantiFERON-TB Gold in-tube due to high nil concentration and methodological exploration and improvement
inferred← citeshttps://doi.org/10.1016/j.ccm.2019.07.007openalex-snapshot
Diagnostic Tests for Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2023.116131openalex-snapshot
Increased rates of indeterminate results in QuantiFERON-TB gold in-tube during the COVID-19 epidemic in Hunan province, China
inferred← citeshttps://doi.org/10.1016/j.jiac.2020.01.011openalex-snapshot
Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus
inferred← citeshttps://doi.org/10.1016/j.jinf.2019.08.018openalex-snapshot
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jinf.2020.02.007openalex-snapshot
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis
inferred← citeshttps://doi.org/10.1016/j.jinf.2020.02.009openalex-snapshot
Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection
inferred← citeshttps://doi.org/10.1016/j.lanepe.2025.101416openalex-snapshot
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study
inferred← citeshttps://doi.org/10.1016/j.mores.2026.100035openalex-snapshot
ESAT-6 and CFP-10 in tuberculosis: bridging virulence to diagnostic applications
inferred← citeshttps://doi.org/10.1093/cid/ciaa030openalex-snapshot
Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1093/cid/ciaa1135openalex-snapshot
Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV)
inferred← citeshttps://doi.org/10.1093/cid/ciaa1822openalex-snapshot
Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1093/cid/ciad030openalex-snapshot
Assessing the Diagnostic Performance of New Commercial Interferon-γ Release Assays forMycobacterium tuberculosisInfection: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1097/mot.0000000000000885openalex-snapshot
Mycobacterium tuberculosis in solid organ transplant donors and recipients
inferred← citeshttps://doi.org/10.1111/tid.13999openalex-snapshot
The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidates
inferred← citeshttps://doi.org/10.1128/jcm.01347-19openalex-snapshot
Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers
inferred← citeshttps://doi.org/10.1128/jcm.01854-19openalex-snapshot
Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples
inferred← citeshttps://doi.org/10.1128/jcm.01950-19openalex-snapshot
Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?
inferred← citeshttps://doi.org/10.1128/spectrum.01858-22openalex-snapshot
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production
inferred← citeshttps://doi.org/10.1128/spectrum.01870-21openalex-snapshot
Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2021-217592openalex-snapshot
Performance of QuantiFERON-TBGold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study
inferred← citeshttps://doi.org/10.1155/2020/7159485openalex-snapshot
Comparison between the Interferon γ Release Assay—QuantiFERON Gold Plus (QFT-Plus)—and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Children
inferred← citeshttps://doi.org/10.11606/t.5.2023.tde-02062023-150104openalex-snapshot
Infecção latente por Mycobacterium tuberculosis em transplante de células tronco hematopoiéticas
inferred← citeshttps://doi.org/10.1186/s12879-023-08008-2openalex-snapshot
Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1513/annalsats.202207-592rlopenalex-snapshot
Interferon-γ Release Assay Test Performance among Immunosuppressant Drug Recipients
inferred← citeshttps://doi.org/10.1515/cclm-2023-0293openalex-snapshot
Comparison of interferon-gamma production between TB1 and TB2 tubes of QuantiFERON-TB Gold Plus: a meta-analysis
inferred← citeshttps://doi.org/10.15406/ghoa.2022.13.00501openalex-snapshot
QuantiFERON-TB gold plus in liver transplant candidates: single-center experience
inferred← citeshttps://doi.org/10.21037/jtd.2019.12.11openalex-snapshot
Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects
inferred← citeshttps://doi.org/10.22541/au.165346205.54294675/v1openalex-snapshot
Challenging Detection of Latent Tuberculosis in a Patient Undergoing High-Dose Corticosteroid Therapy for Acute Hemolytic Anemia and Rhupus Arthropathy
inferred← citeshttps://doi.org/10.22541/au.165346205.54294675/v2openalex-snapshot
Challenging Detection of Latent Tuberculosis in a Patient Undergoing High-Dose Corticosteroid Therapy for Acute Hemolytic Anemia and Rhupus Arthropathy
inferred← citeshttps://doi.org/10.33073/pjm-2021-042openalex-snapshot
QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1–14 in a Country with a Low Tuberculosis Incidence
inferred← citeshttps://doi.org/10.3389/fped.2019.00291openalex-snapshot
Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
inferred← citeshttps://doi.org/10.3390/jcm10071376openalex-snapshot
Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
inferred← citeshttps://doi.org/10.3390/life12020244openalex-snapshot
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production
inferred← citeshttps://doi.org/10.3390/pathogens10050535openalex-snapshot
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test
inferred← citeshttps://doi.org/10.3904/kjim.2019.002openalex-snapshot
QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection
inferred← citeshttps://doi.org/10.3904/kjim.2020.048openalex-snapshot
Successful transition to the QFT-PLUS assay, but more is needed for diagnosis of latent tuberculosis infection
inferred← citeshttps://doi.org/10.4285/kjt.2020.34.1.8openalex-snapshot
Comparative evaluation of QuantiFERON-TB Gold Plus for diagnosis of latent tuberculosis infection during solid organ transplantation
inferred← citeshttps://doi.org/10.47429/lmo.2023.13.2.85openalex-snapshot
Analysis of Positive Patterns and Follow-up Results of the QuantiFERON-TB Gold-Plus Test in the Screening of Patients and Healthcare Workers
inferred← citeshttps://doi.org/10.6084/m9.figshare.22614430openalex-snapshot
Additional file 1 of Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.7717/peerj.19195openalex-snapshot
Performance comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in detecting Mycobacterium tuberculosis infection among HIV patients in China
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.